Literature DB >> 4905153

Toxicity of E. coli L-asparaginase in man.

H F Oettgen, P A Stephenson, M K Schwartz, R D Leeper, L Tallai, C C Tan, B D Clarkson, R B Golbey, I H Krakoff, D A Karnofsky, M L Murphy, J H Burchenal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4905153     DOI： 10.1002/1097-0142(197002)25:2<253::aid-cncr2820250204>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  43 in total

1.  Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors:  Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

2.  Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.

Authors:  C Liu; J D Kawedia; C Cheng; D Pei; C A Fernandez; X Cai; K R Crews; S C Kaste; J C Panetta; W P Bowman; S Jeha; J T Sandlund; W E Evans; C-H Pui; M V Relling
Journal:  Leukemia       Date:  2012-04-09       Impact factor: 11.528

Review 3.  What makes a good new therapeutic L-asparaginase?

Authors:  Angela Beckett; David Gervais
Journal:  World J Microbiol Biotechnol       Date:  2019-09-24       Impact factor: 3.312

4.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

5.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Authors:  S-H Chen; D Pei; W Yang; C Cheng; S Jeha; N J Cox; W E Evans; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

6.  Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia.

Authors:  E Nagura; K Kimura; K Yamada; K Ota; T Maekawa; F Takaku; H Uchino; T Masaoka; I Amaki; K Kawashima
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Authors:  H B Muss; N Spell; D Scudiery; R L Capizzi; M R Cooper; J Cruz; D V Jackson; F Richards; C L Spurr; D R White
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  Parathyroid necrosis and hypocalcemic tetany induced in rabbits by L-asparaginase.

Authors:  F V Chisari; H D Hochstein; R L Kirschstein; E B Seligmann
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

Review 9.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

10.  Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.

Authors:  L M Botana; E Arnaez; M R Vieytes; A Alfonso; M C Louzao
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.